Spots Global Cancer Trial Database for advanced soft tissue sarcoma
Every month we try and update this database with for advanced soft tissue sarcoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Multicenter, Prospective, oBservational Study to assEss the Clinical activitY and Impact on symptOm Burden and patieNts' HRQoL of Treatment With trabecteDin in aSTS in a Real World Setting in Greece | NCT02618122 | Advanced Soft T... | 18 Years - | Genesis Pharma S.A. | ||
| A Study of Doxorubicin Plus Olaratumab (LY3012207) in Participants With Advanced or Metastatic Soft Tissue Sarcoma | NCT02451943 | Soft Tissue Sar... | Olaratumab Doxorubicin Placebo | 18 Years - | Eli Lilly and Company | |
| Gemcitabine Plus Rapamycin Versus Gemcitabine to Treat Advanced Soft Tissue Sarcoma | NCT01684449 | Advanced Soft T... | Gemcitabine + R... | 18 Years - 70 Years | Grupo Espanol de Investigacion en Sarcomas | |
| NAPAGE: NAb-PAclitaxel and GEmcitabine in Advanced Soft Tissue Sarcoma | NCT03524898 | Soft Tissue Sar... | Nab-Paclitaxel gemcitabine | 18 Years - | Swiss Group for Clinical Cancer Research | |
| OlaReDo - Olaratumab and Rechallenge With Doxorubicin in Soft Tissue Sarcoma Patients | NCT03698227 | Advanced Soft T... | Olaratumab Dexrazoxane Doxorubicin | 18 Years - | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | |
| Testing Atezolizumab With or Without Selinexor in Patients >= 18 Years Old With Alveolar Soft Part Sarcoma, the Axiom Study | NCT05333458 | Advanced Alveol... Advanced Soft T... Metastatic Alve... Unresectable Al... | Atezolizumab Biopsy Biospecimen Col... Computed Tomogr... Magnetic Resona... Selinexor | 18 Years - | National Cancer Institute (NCI) | |
| Nab-Sirolimus and Pazopanib Hydrochloride in Treating Patients With Advanced Nonadipocytic Soft Tissue Sarcomas | NCT03660930 | Advanced Soft T... Locally Advance... Metastatic Soft... | Sirolimus Album... Pazopanib hydro... | 18 Years - | University of Washington | |
| A Study of Doxorubicin Plus Olaratumab (LY3012207) in Participants With Advanced or Metastatic Soft Tissue Sarcoma | NCT02451943 | Soft Tissue Sar... | Olaratumab Doxorubicin Placebo | 18 Years - | Eli Lilly and Company | |
| Geno-radiomics Based Model for Evaluation of Immunotherapy and Targeted Therapy for Advanced Soft Tissue Sarcoma | NCT06062927 | Advanced Soft T... | 18 Years - 75 Years | Peking Union Medical College Hospital | ||
| Randomized Trial in Advanced, Metastatic or Unresectable Soft Tissue Sarcoma After Failure of Standard Treatments. | NCT03838744 | Advanced Soft T... | Standard arm: T... Experimental ar... | 18 Years - | Italian Sarcoma Group | |
| Itacitinib in Treating Patients With Refractory Metastatic/Advanced Sarcomas | NCT03670069 | Metastatic Leio... Metastatic Syno... Metastatic Undi... Advanced Myxoid... Advanced Soft T... Metastatic Myxo... Metastatic Roun... Metastatic Soft... Refractory Leio... Refractory Myxo... Refractory Roun... Refractory Soft... Refractory Syno... Refractory Undi... Advanced Leiomy... Advanced Synovi... Advanced Undiff... Metastatic Chon... | Itacitinib Laboratory Biom... | 18 Years - | Fred Hutchinson Cancer Center | |
| Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by Surgery | NCT03009201 | Advanced Soft T... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Metastatic Angi... Metastatic Epit... Metastatic Fibr... Metastatic Lipo... Metastatic Mali... Metastatic Myxo... Metastatic Soft... Metastatic Syno... Metastatic Undi... Myxofibrosarcom... Pleomorphic Rha... Stage III Soft ... Stage IV Soft T... Undifferentiate... Unresectable Le... Unresectable Li... Unresectable Ma... Unresectable So... Unresectable Sy... Unresectable Un... | Doxorubicin Hyd... Laboratory Biom... Pharmacological... Ribociclib | 12 Years - | OHSU Knight Cancer Institute | |
| A Multicenter, Prospective, oBservational Study to assEss the Clinical activitY and Impact on symptOm Burden and patieNts' HRQoL of Treatment With trabecteDin in aSTS in a Real World Setting in Greece | NCT02618122 | Advanced Soft T... | 18 Years - | Genesis Pharma S.A. | ||
| Gemcitabine Plus Rapamycin Versus Gemcitabine to Treat Advanced Soft Tissue Sarcoma | NCT01684449 | Advanced Soft T... | Gemcitabine + R... | 18 Years - 70 Years | Grupo Espanol de Investigacion en Sarcomas | |
| Randomized Trial in Advanced, Metastatic or Unresectable Soft Tissue Sarcoma After Failure of Standard Treatments. | NCT03838744 | Advanced Soft T... | Standard arm: T... Experimental ar... | 18 Years - | Italian Sarcoma Group | |
| Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by Surgery | NCT03009201 | Advanced Soft T... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Metastatic Angi... Metastatic Epit... Metastatic Fibr... Metastatic Lipo... Metastatic Mali... Metastatic Myxo... Metastatic Soft... Metastatic Syno... Metastatic Undi... Myxofibrosarcom... Pleomorphic Rha... Stage III Soft ... Stage IV Soft T... Undifferentiate... Unresectable Le... Unresectable Li... Unresectable Ma... Unresectable So... Unresectable Sy... Unresectable Un... | Doxorubicin Hyd... Laboratory Biom... Pharmacological... Ribociclib | 12 Years - | OHSU Knight Cancer Institute | |
| OlaReDo - Olaratumab and Rechallenge With Doxorubicin in Soft Tissue Sarcoma Patients | NCT03698227 | Advanced Soft T... | Olaratumab Dexrazoxane Doxorubicin | 18 Years - | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | |
| Testing Atezolizumab With or Without Selinexor in Patients >= 18 Years Old With Alveolar Soft Part Sarcoma, the Axiom Study | NCT05333458 | Advanced Alveol... Advanced Soft T... Metastatic Alve... Unresectable Al... | Atezolizumab Biopsy Biospecimen Col... Computed Tomogr... Magnetic Resona... Selinexor | 18 Years - | National Cancer Institute (NCI) | |
| A Study of Axitinib in Patients With Advanced Angiosarcoma and Other Soft Tissue Sarcomas | NCT01140737 | Soft Tissue Sar... | Axitinib | 16 Years - | Sheffield Teaching Hospitals NHS Foundation Trust | |
| Brightline-3: A Study to Find Out Whether Brigimadlin in Combination With Ezabenlimab Helps People With Advanced Soft Tissue Sarcoma | NCT06370871 | Advanced Soft T... Undifferentiate... Myxofibrosarcom... | Brigimadlin Ezabenlimab Gemcitabine Docetaxel | 18 Years - | Boehringer Ingelheim | |
| Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by Surgery | NCT03009201 | Advanced Soft T... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Metastatic Angi... Metastatic Epit... Metastatic Fibr... Metastatic Lipo... Metastatic Mali... Metastatic Myxo... Metastatic Soft... Metastatic Syno... Metastatic Undi... Myxofibrosarcom... Pleomorphic Rha... Stage III Soft ... Stage IV Soft T... Undifferentiate... Unresectable Le... Unresectable Li... Unresectable Ma... Unresectable So... Unresectable Sy... Unresectable Un... | Doxorubicin Hyd... Laboratory Biom... Pharmacological... Ribociclib | 12 Years - | OHSU Knight Cancer Institute |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
